No material insider buying or selling detected. The small open-market sales by two executives are routine and not a cause for concern. Monitor upcoming earnings or clinical trial updates as potential catalysts, but this cluster does not suggest material non-public information.
Price Chart
Executive Summary
Intellia Therapeutics insiders executed a mix of open-market sales and stock awards over the past week. Two executives sold shares totaling ~$25K, while six insiders received non-cash stock grants totaling over 276K shares. The sales are minor relative to market cap and likely routine, while the grants are standard compensation events.
Key Financial Metrics
Key Facts
- EVP and CTO Eliana Clark sold 607 shares for $8,364.46 on March 2, 2026
- EVP and General Counsel James Basta sold 1,211 shares for $16,687.58 on March 2, 2026
- Six insiders received stock grants totaling 276,223 shares on March 1, 2026, valued at $0 (non-cash)
- Total open-market sales in cluster: $25,052.04
- All transactions occurred within a 7-day window, forming an SEC-reported cluster
Financial Impact
$25,052 in open-market sales; $0 from grants (non-cash). Total economic outflow: negligible (<0.002% of $1.8B market cap)
Risk Factors
- Perception risk if investors misinterpret routine sales as negative signal
- Future dilution possible when granted shares vest, though standard for biotech firms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-NTLA-1772573053200 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 23d ago | Press Release | $12.75 $12.58 | ▼ −1.33% | ▼ −1.76% | $11.23 (−11.92%) |
Sep 8, 2026 6w ago | 8-K | $12.21 $11.60 | ▼ −5.00% | ▼ −4.66% | $11.23 (−8.03%) |
Aug 6, 2026 11w ago | 8-K | $11.24 $11.83 | ▲ +5.25% | ▲ +4.04% | $11.23 (−0.09%) |
Jun 15, 2026 19w ago | 8-K | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $11.23 (−24.73%) |
Jun 13, 2026 19w ago | Press Release | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $11.23 (−24.73%) |
Jun 1, 2026 21w ago | Press Release | $13.73 $13.54 | ▼ −1.38% | ▲ +1.37% | $11.23 (−18.21%) |
May 11, 2026 24w ago | 8-K | $14.42 $12.69 | ▼ −12.00% | ▼ −11.91% | $11.23 (−22.12%) |
Apr 27, 2026 25w ago | Press Release | $13.20 $13.87 | ▼ −5.08% | ▼ −3.38% | $11.23 (+14.92%) |
Apr 27, 2026 26w ago | 8-K | $13.04 $13.87 | ▲ +6.37% | ▲ +5.96% | $11.23 (−13.88%) |
Apr 3, 2026 29w ago | Press Release | $13.30 $14.26 | ▲ +7.22% | ▲ +3.08% | $11.23 (−15.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers